What other stocks do shareholders of Novelion Therapeutics Inc, own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Novelion Therapeutics Inc, investors own include Alnylam Pharmaceuticals (ALNY) , NXP Semiconductors (NXPI) , Whole Foods Market (WFM) , InvenSense (INVN) , OPKO Health (OPK) , Vitamin Shoppe (VSI) , Aurora Cannabis (ACB) , ABGBY (ABGBY) , Gilead Sciences (GILD) and 3D Systems (DDD) .

How do I buy shares of Novelion Therapeutics Inc,?

Shares of NVLN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

TSE:NVLN

Novelion Therapeutics Inc, (NVLN) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free NVLN Stock Alerts

Compare

Today's Range: N/A
50-Day Range: C$13.30
▼
C$13.30
52-Week Range: N/A

Volume: 3,639 shs
Average Volume: 3,220 shs
Market Capitalization: C$251.80 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Novelion Therapeutics Inc, alerts:

Ad Behind the Markets

Will this $2 AI stock double overnight?

It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!

Click here to learn more >>>

About Novelion Therapeutics Inc,

Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company's portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.

Ad Behind the Markets

Will this $2 AI stock double overnight?

It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!

Click here to learn more >>>

NVLN Stock News Headlines

April 18, 2024 | investing.com

Vivos Therapeutics Inc (VVOS)

March 24, 2024 | morningstar.com

Century Therapeutics Inc IPSC

April 19, 2024 | Weiss Ratings (Ad)

The only accurate crypto trading system I know …

Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.

February 14, 2024 | wsj.com

CymaBay Therapeutics Inc.

February 6, 2024 | investing.com

Aclaris Therapeutics Inc (ACRS)

January 3, 2024 | investing.com

HighTide Therapeutics Inc (2511)

December 30, 2023 | investing.com

Intensity Therapeutics Inc (INTS)

December 17, 2023 | morningstar.com

Leap Therapeutics Inc LPTX

April 19, 2024 | Weiss Ratings (Ad)

The only accurate crypto trading system I know …

November 14, 2023 | morningstar.com

Aileron Therapeutics Inc ALRN

November 11, 2023 | morningstar.com

Atossa Therapeutics Inc ATOS

November 1, 2023 | morningstar.com

Beam Therapeutics Inc BEAM

November 1, 2023 | morningstar.com

Aprea Therapeutics Inc APRE

November 1, 2023 | morningstar.com

Celldex Therapeutics Inc CLDX

October 31, 2023 | morningstar.com

CARISMA Therapeutics Inc CARM

September 29, 2023 | finance.yahoo.com

Is Viking Therapeutics, Inc. a Buy?

August 26, 2023 | seekingalpha.com

IMUN Immune Therapeutics, Inc.

August 24, 2023 | seekingalpha.com

ELVN Enliven Therapeutics, Inc.

May 10, 2023 | morningstar.com

Sigilon Therapeutics Inc Ordinary Shares

April 25, 2023 | finance.yahoo.com

Sarepta Therapeutics, Inc. (SRPT)

April 20, 2023 | morningstar.com

Nurix Therapeutics Inc Ordinary Shares

April 20, 2023 | seekingalpha.com

ZVSA ZyVersa Therapeutics, Inc.

March 26, 2023 | finanznachrichten.de

Defence Therapeutics Inc.: Defence Therapeutics Announces Exercise of Warrants for Gross Proceeds of over $5 Million

February 26, 2023 | benzinga.com

Windtree Therapeutics Stock (NASDAQ:WINT), Quotes and News Summary

January 28, 2023 | seekingalpha.com

FDMT 4D Molecular Therapeutics, Inc.

January 27, 2023 | seekingalpha.com

AVTE Aerovate Therapeutics, Inc.

January 24, 2023 | seekingalpha.com

RUBY Rubius Therapeutics, Inc.

See More Headlines

Receive NVLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novelion Therapeutics Inc, and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: TSE
Sector: Manufacturing
Industry: Electronic Computer Manufacturing
Sub-Industry: N/A
Current Symbol: TSE:NVLN
Previous Symbol: TSE:QLT
CUSIP: N/A
CIK: N/A
Web: www.novelion.com
Phone: +1-604-7077000
Fax: N/A
Employees: 109
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 18,932,000
Free Float: N/A
Market Cap: C$251.80 million
Optionable: Not Optionable
Beta: N/A

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Competitors

View All Competitors

NVLN Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Novelion Therapeutics Inc, own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Novelion Therapeutics Inc, investors own include Alnylam Pharmaceuticals (ALNY), NXP Semiconductors (NXPI), Whole Foods Market (WFM), InvenSense (INVN), OPKO Health (OPK), Vitamin Shoppe (VSI), Aurora Cannabis (ACB), ABGBY (ABGBY), Gilead Sciences (GILD) and 3D Systems (DDD).
How do I buy shares of Novelion Therapeutics Inc,?: Shares of NVLN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:NVLN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Novelion Therapeutics Inc, (NVLN) Stock Price, News & Analysis

About Novelion Therapeutics Inc,

NVLN Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Competitors

NVLN Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info